Search

Showing total 57 results
Start Over Topic buprenorphine Language english Database Gale General OneFile
57 results

1. ASAM elaborates on its buprenorphine dosing paper

Subjects
Mechanical contractors, Buprenorphine, Government, Health, Psychology and mental health
Abstract

Last week, ADAW featured a published paper recommending that higher doses of buprenorphine be used in the era of fentanyl (see 'ASAM recommends higher doses if needed for treatment with [...]

Published
2024

2. Jail inmates now getting drug-soaked paper through mail, jails moving to stop it

Subjects
Prisoners, Buprenorphine, Business, Computers and office automation industries, Telecommunications industry
Abstract

Byline: Tom Jackman Never underestimate the ingenuity, or desperation, of drug-addicts. In southwestern Virginia, jail officials have intercepted photos and other papers soaked in liquid suboxone, a substance used to [...]

Published
2016

3. AATOD white paper details how OTPs and buprenorphine providers can collaborate

Subjects
Health care industry, Buprenorphine, Health care industry, Family and marriage, Health, Psychology and mental health
Abstract

A new report from the American Association for the Treatment of Opioid Dependence (AATOD) focuses on how opioid treatment programs (OTPs) can collaborate with other health care providers, including office-based [...]

Published
2016

4. ASAM recommends higher doses if needed for treatment with buprenorphine

Subjects
Buprenorphine, Government, Health, Psychology and mental health
Abstract

In a clear but measured and scientific dispute against standard practice today, the American Society of Addiction Medicine (ASAM) has called for an end to the standardization of doses of [...]

Published
2024

6. Help and Hope For People With Addiction

Author

Interlandi, Jeneen and Winter, Damon

Subjects
United States. Centers for Medicare and Medicaid Services, Buprenorphine, Physicians, Evidence-based medicine, General interest, News, opinion and commentary
Abstract

Raina Mcmahan, a 42-year-old recovery coach, spent roughly half her life seeking treatment for her own opioid use disorder. She tried detoxing multiple times at different inpatient facilities, but those [...]

Published
2023

7. Study of telehealth opioid treatment shows feasibility of remote testing

Subjects
Buprenorphine, Evidence-based medicine, Government, Health, Psychology and mental health
Abstract

Results of a new observational study suggest that urine drug screening in telehealth-based treatment for opioid use disorder (OUD) is highly feasible and not inherently more prone to unexpected results [...]

Published
2023

8. SAMHSA and FDA move toward 'medication only'

Subjects
United States. Food and Drug Administration, Mental health, Buprenorphine, Government, Health, Psychology and mental health
Abstract

Receiving buprenorphine should not be contingent upon receiving counseling as well, the federal government has said in a 'Dear Colleague' letter issued May 9. The letter, from the Food and [...]

Published
2023

9. New Opioids Study Findings Have Been Reported by Researchers at University of California San Francisco (UCSF) (Discontinuing Methadone and Buprenorphine: a Review and Clinical Challenges)

Subjects
United States. National Institutes of Health, Central nervous system depressants, Buprenorphine, Physical fitness, Methadone hydrochloride, Health, University of California
Abstract

2021 DEC 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Opioids. According to news reporting originating in [...]

Published
2021

10. Digital provider delivering bupe sets out to be long-term presence with VC funding

Subjects
Buprenorphine, Venture capital, Venture capital companies -- Finance, Evidence-based medicine, Company financing, Venture capital, Government, Health, Psychology and mental health
Abstract

A digital opioid addiction treatment program that as of late 2021 had raised around $68 million in capital financing has made it clear that it sees buprenorphine treatment delivered virtually [...]

Published
2022

11. Negative views toward agonists manifest in tapering, feelings of mistrust

Subjects
Buprenorphine, Pharmaceutical industry, Government, Health, Psychology and mental health
Abstract

Even in service settings that accept the use of methadone and buprenorphine as part of treatment, stigmatizing attitudes toward the medications' role can result in treatment decisions that conflict with [...]

Published
2022

12. Reports Outline Opioids Findings from University of Cincinnati College of Medicine [Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and ...]

Subjects
Elsevier Science Inc. -- Reports, Periodical publishing -- Research -- Analysis -- Reports, Physical fitness -- Research -- Analysis -- Reports, Opioid abuse -- Research -- Care and treatment, Evidence-based medicine -- Analysis -- Research -- Reports, Pregnant women -- Care and treatment, Opioids -- Research, Obesity, Buprenorphine, Evidence-based practice, Editors, Health, University of Cincinnati. College of Medicine -- Reports
Abstract

2020 MAY 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Opioids are discussed in a new report. According to [...]

Published
2020

13. PureTech Announces Publication of Research from Collaborators Demonstrating PureTech's Glyph[TM] Platform Enhances Oral Absorption of Buprenorphine (a Clinically-Validated Opioid Replacement Therapy)

Subjects
Buprenorphine, Business, Business, international
Abstract

Bioavailability of buprenorphine up to 20-fold higher in preclinical models using prodrug generated with the Glyph technology, driven by transport of prodrug through the gut-draining lymphatics The research published in [...]

Published
2022

14. Even as overdose deaths soar, pharmacies won't dispense addiction meds for fear of DEA

Subjects
United States. Drug Enforcement Administration -- Officials and employees, Drugs -- Overdose, Buprenorphine, Drugstores -- Officials and employees, Pharmacy, Business, General interest, Business, regional, Subutex (Medication), Suboxone (Medication)
Abstract

Byline: Aneri Pattani Nov. 11When Martin Njoku saw opioid addiction devastate his West Virginia community, he felt compelled to help. This was the place he'd called home for three decades, [...]

Published
2021

15. Revisiting the X:BOT trial comparing ER naltrexone and buprenorphine

Subjects
Naltrexone, Drugs -- Overdose, Buprenorphine, Government, Health, Psychology and mental health, Vivitrol (Medication)
Abstract

More than four years after the X:BOT study showing that buprenorphine and extended-release (ER) naltrexone (Vivitrol) were even in a head-to-head randomized trial, a new analysis 'revisiting' the study data [...]

Published
2022

16. Drug users who only need treatment should get it, not arrest and incarceration

Subjects
Buprenorphine, Government, Health, Psychology and mental health, Vivitrol (Medication)
Abstract

Many changes at the local, state and federal levels have resulted in getting treatment to at least some people with opioid use disorder (OUD) in prisons and jails--treatment that just [...]

Published
2019

17. Studies from J.S. Carey and Co-Authors Have Provided New Information about Central Nervous System Agents (Process Development Toward a Pro-drug of Buprenorphine)

Subjects
Physical fitness, Central nervous system, Central nervous system agents, Buprenorphine, Obesity, Drugs, Nervous system agents, Editors, Health
Abstract

2019 JUN 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Drugs and Therapies - Central Nervous System [...]

Published
2019

18. Researchers at University of Bath Release New Data on Drugs Used In Alcohol Dependence (Simultaneous Transdermal Delivery of Buprenorphine Hydrochloride and Naltrexone Hydrochloride by Iontophoresis)

Subjects
Physical fitness, Transdermal drug delivery systems, Alcoholism, Naltrexone, Drug abuse, Buprenorphine, Drug delivery systems, Obesity, Substance abuse treatment, Addiction, Opioids, Editors, Health
Abstract

2019 JUN 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Drugs and Therapies - Drugs Used In [...]

Published
2019

19. Removing barriers to opioid use disorder treatment shows success during pandemic

Subjects
Epidemics -- Care and treatment -- Prevention -- Pennsylvania, Mental health, Drugs -- Prescribing, Buprenorphine, Health, Psychology and mental health
Abstract

2022 JUN 20 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Pandemic-era changes to prescribing guidelines for the lifesaving drug buprenorphine led to improved [...]

Published
2022

20. Pear Therapeutics Announces Publication of Real-World Data Showing Improved Clinical Outcomes with a Subsequent Prescription of reSET-O[R] for Patients with Opioid Use Disorder

Subjects
United States. Food and Drug Administration, Buprenorphine, Substance abuse -- Care and treatment, Business, Business, international
Abstract

* reSET-O[R] is the first and only FDA-authorized Prescription Digital Therapeutic (PDT) for the treatment of opioid use disorder (OUD) * This new analysis examined real-world health outcome data from [...]

Published
2021

21. Philly DA Larry Krasner will no longer prosecute people for possession of an addiction treatment drug

Subjects
Substance abuse treatment, Overdose, Drug abuse, Prescriptions (Drugs), Buprenorphine, Addiction, Business, General interest, Business, regional
Abstract

Byline: Aubrey Whelan Jan. 29-- Jan. 29--The Philadelphia District Attorney's office has decided to stop prosecuting people for possessing buprenorphine -- the opioid-based addiction treatment drug proven to give people [...]

Published
2020

22. Cops: McKees Rocks woman tried to smuggle drugs into Somerset prison

Subjects
Prisons, Police officers, Buprenorphine, Marijuana, General interest, News, opinion and commentary
Abstract

Byline: Patrick Varine Nov. 19-- Nov. 19--A McKees Rocks woman has been charged with attempting to smuggle drugs into a Somerset County prison on Nov. 14. State police charged Christine [...]

Published
2019

23. After the X-waiver: Next steps to increase access

Subjects
Buprenorphine, Government, Health, Psychology and mental health
Abstract

The Foundation for Opioid Response Efforts (FORE), a national grant-making organization, in a March 9 webinar focused on access to treatment to buprenorphine. FORE recognized early on (when it launched [...]

Published
2023

24. Overdose Crisis Endures, Yet Few People Receive Existing Effective Treatment

Subjects
United States. Drug Enforcement Administration, Opioid abuse, Evidence-based medicine, Drug approval, Charitable trusts, Buprenorphine, General interest, News, opinion and commentary, RAND Corp., Pew Charitable Trusts
Abstract

NEW YORK: Deerfield Management has issued the following press release: Approximately half of clinicians authorized to prescribe buprenorphine for opioid use disorder (OUD), one of three medications for OUD, are [...]

Published
2020

25. Overdose Crisis Endures, Yet Few People Receive Existing Effective Treatment

Subjects
United States. Drug Enforcement Administration, Opioid abuse, Evidence-based medicine, Drug approval, Charitable trusts, COVID-19, Buprenorphine, Business, Business, international, RAND Corp., Pew Charitable Trusts
Abstract

Even before Covid-19, despite enormous unmet need, life-saving buprenorphine is vastly underprescribed NEW YORK -- Approximately half of clinicians authorized to prescribe buprenorphine for opioid use disorder (OUD), one of [...]

Published
2020

26. Opioid misuse treatment during pregnancy may impact child development

Subjects
Opioid abuse -- Care and treatment -- Reports, Evidence-based medicine -- Reports, Child development -- Reports, Drug abuse -- Care and treatment -- Reports, Pregnant women -- Care and treatment -- Reports, Buprenorphine, Substance abuse treatment, Children, General interest, News, opinion and commentary
Abstract

Byline: BRIAN P. DUNLEAVY Treatment of opioid addiction in pregnant mothers may be as harmful to their unborn children as the drugs themselves, a review of existing research has found, [...]

Published
2020

27. Ohio Jail Receives Letter With Drugs Inside From Fake Address

Subjects
Drugs, Buprenorphine, Newspapers, Business, international, News, opinion and commentary
Abstract

An unidentified person tried to send drugs to an inmate at the Ashtabula County jail in Ohio, a police report revealed. The suboxone strips were slid inside two photographs glued [...]

Published
2020

28. Doctors should avoid co-prescribing benzodiazepines to opioid dependent patients due to increase in overdose death

Subjects
Benzodiazepines, Physicians, Prescription writing, Antianxiety agents, Zaleplon, Overdose -- Care and treatment, Death, Buprenorphine, Business, international, University of Bristol
Abstract

London: University of Bristol, UK Government has issued the following news release: Doctors should avoid co-prescribing benzodiazepines to opioid dependent patients who are being treated with methadone or buprenorphine, also [...]

Published
2019

29. Buprenorphine and Vivitrol perform equally well in head-to-head study

Subjects
United States. National Institute on Drug Abuse, Medical research, Buprenorphine, Family and marriage, Health, Psychology and mental health, Vivitrol (Medication), Suboxone (Medication)
Abstract

The first head-to-head study comparing buprenorphine-naloxone with extended-release naltrexone in the United States has found both medications are equally successful at retaining patients 6 months later. The study, published online [...]

Published
2017

30. White patients far more likely to get popular addiction treatment prescription, study finds

Subjects
Buprenorphine, Substance abuse treatment, Opioid abuse, Addiction, Medical societies, Health, Physicians, Business, General interest, Business, regional, University of Michigan
Abstract

Byline: Aubrey Whelan An addiction treatment drug that health officials around the country have touted as a crucial part of the battle against the opioid epidemic is prescribed far more [...]

Published
2019

31. Nonphysician workforce increasingly drives opioid use disorder treatment in rural America

Author

Oakes, Kari

Subjects
Physicians' assistants -- Practice -- Laws, regulations and rules -- Usage, Opioid abuse -- Care and treatment, Nurse practitioners -- Practice -- Laws, regulations and rules -- Usage, Rural health services -- Laws, regulations and rules -- Usage, Medical practice -- Laws, regulations and rules -- Usage, Prescriptions (Drugs) -- Usage -- Laws, regulations and rules, Evidence-based medicine, Nurses, Registered nurses, Buprenorphine, Midwives, Rural health, Prescription writing, Overdose, Government regulation, Health
Abstract

Nurse practitioners and physician assistants, rather than physicians, are the clinicians who have boosted capacity for buprenorphine prescribing in rural America, according to a study in a rural health-focused issue [...]

Published
2020

32. Study: Stress, not low motivation, at heart of OUD treatment dropout

Subjects
Buprenorphine, Substance abuse -- Care and treatment, Government, Health, Psychology and mental health
Abstract

For addiction treatment center staffers who might tend to assume that a patient dropping out of treatment was essentially not ready to receive help, results from a newly published study [...]

Published
2019

33. Marijuana as treatment for OUDs? Most medical experts say no

Subjects
Medical marijuana -- Usage, Opioid abuse -- Care and treatment, Nabilone, Substance abuse, Mental health, Neurophysiology, Buprenorphine, Health, Social services, Marijuana, Government, Health, Psychology and mental health
Abstract

Gov. Andrew Cuomo of New York has added opioid use disorders (OUDs) to the list of approved conditions for which medical marijuana could be prescribed in the state, following the [...]

Published
2019

34. Cascade of Care approach to opioid crisis would incentivize MAT: Study

Subjects
HIV infections -- Risk factors -- Prevention, Opioid abuse -- Complications and side effects -- Drug therapy, Substance abuse treatment -- Methods, Patient care, Naltrexone, HIV, Buprenorphine, Evidence-based medicine, Public health, Government, Health, Psychology and mental health
Abstract

Adoption of a unified public health framework for the treatment of opioid use disorders (OUDs) would encourage more continuity of care and use of evidence-based medication treatments to combat the [...]

Published
2019

35. Medicare Part D plans have removed barriers to opioid use disorder medications

Subjects
Mortality, Opioid abuse, Medicare, Drugs, Buprenorphine, Death, Health insurance, Naloxone, Addiction, Medical societies, General interest, News, opinion and commentary, Legal Action Center
Abstract

New York: Legal Action Center has issued the following press release: Opioid death rates continue to rise, having reached 48,000 in 2017. Opioid use disorder medications can cut a patient's [...]

Published
2019

36. Medicare Part D plans have removed barriers to opioid use disorder medications

Subjects
Mortality, Opioid abuse, Medicare, Drugs, Buprenorphine, Health insurance, Naloxone, Addiction, Medical societies, Banking, finance and accounting industries, Business, Legal Action Center, Research Triangle Institute
Abstract

RESEARCH TRIANGLE PARK, July 09, Jul 09, 2019 (GLOBE NEWSWIRE via COMTEX) -- Opioid death rates continue to rise, having reached 48,000 in 2017. Opioid use disorder medications can cut [...]

Published
2019

37. Overdose Crisis Endures, Yet Few People Receive Existing Effective Treatment

Subjects
United States. Drug Enforcement Administration, Opioid abuse, Evidence-based medicine, Mental health, Charitable trusts, Drug approval, Buprenorphine, Health, Psychology and mental health, RAND Corp., Pew Charitable Trusts
Abstract

2020 SEP 7 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Approximately half of clinicians authorized to prescribe buprenorphine for opioid use disorder (OUD), [...]

Published
2020

38. Findings from University of Toronto Broaden Understanding of HIV/AIDS (Effectiveness of opiate substitution treatment in reducing HIV risk behaviors among African, Caribbean and black people: a systematic review protocol)

Subjects
Sexual behavior -- Behavior -- Research, HIV -- Research -- Risk factors, Medical research, Buprenorphine, AIDS (Disease), Immune system, Substance abuse, Editors, Diseases, Health, University of Toronto
Abstract

2020 MAY 18 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Current study results on Immune System Diseases and Conditions - HIV/AIDS have been published. According [...]

Published
2020

39. Data on HIV/AIDS Reported by Researchers at University of Toronto (Effectiveness of opiate substitution treatment in reducing HIV risk behaviors among African, Caribbean and black people: a systematic review protocol)

Subjects
Sexual behavior -- Reports -- Behavior, HIV -- Risk factors -- Reports -- Behavior, Buprenorphine, AIDS (Disease), Immune system, Substance abuse, Editors, Diseases, Health, University of Toronto -- Reports
Abstract

2020 APR 6 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Fresh data on Immune System Diseases and Conditions - HIV/AIDS are presented in a new [...]

Published
2020

40. Study Examines Effects of Different Opioids on Driving Performance

Subjects
Opioids -- Research -- Reports, Motor vehicle drivers, Pain management, Periodicals, Buprenorphine, Pharmacology, General interest, News, opinion and commentary
Abstract

Hoboken: John Wiley & Sons, Inc. has issued the following press release:Taking opioids for the treatment of pain has been associated with increased risks of crashing among drivers, but it [...]

Published
2018

41. Data from Ryerson University Provide New Insights into HIV/AIDS (Effectiveness of opiate substitution treatment in reducing HIV risk behaviors among African, Caribbean and black people: a systematic review protocol)

Subjects
Sexual behavior -- Behavior, HIV -- Risk factors -- Behavior, Medical research, Buprenorphine, AIDS (Disease), Immune system, Substance abuse, Editors, Health, Ryerson University
Abstract

2019 NOV 4 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Researchers detail new data in Immune System Diseases and Conditions - HIV/AIDS. According to news [...]

Published
2019

42. AAP urges pediatricians to prescribe buprenorphine

Subjects
Pediatricians, Pediatrics, Buprenorphine, Family and marriage, Health, Psychology and mental health, American Academy of Pediatrics
Abstract

In 'Medication-Assisted Treatment of Adolescents With Opioid Use Disorders,' published online August 22, the American Academy of Pediatrics (AAP) urges its members to make buprenorphine available to patients with opioid [...]

Published
2016

43. BUPRENORPHINE PRESCRIBERS TREAT BELOW CURRENT PATIENT LIMITS

Subjects
United States. National Institutes of Health, United States. National Institute on Drug Abuse, Medical research, Buprenorphine, News, opinion and commentary
Abstract

BETHESDA, MD -- The following information was released by the National Institute on Drug Abuse (NIDA): A new NIDA-funded study analysis found that the monthly numbers of opioid use disorder [...]

Published
2016

44. Indivior Inc. Introduces Mobile Application to Help Support Education, Adherence and Disease Management Needs of Patients with Opioid Dependence and Their Physicians

Subjects
Wireless telephone software, Physicians, Patient compliance, Drug abuse, Buprenorphine, Business, News, opinion and commentary, Suboxone (Medication)
Abstract

RICHMOND, Va., March 31, 2016 /PRNewswire/ -- Indivior Inc., announced the launch of its first mobile tool, the SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) Mobile Health Library(TM). This free [...]

Published
2016

45. LAC and RTI: Eliminate Medicaid prior auth for bupe

Subjects
United States. Food and Drug Administration, Medicaid, Buprenorphine, Health insurance, Government, Health, Psychology and mental health, Legal Action Center
Abstract

Since April 2018, Medicare limited utilization management--most often done via prior authorization requirements--for buprenorphine to treat opioid use disorder (OUD). In response, virtually all plans that covered this treatment removed [...]

Published
2019

46. Mixed messages: Marijuana as treatment for OUDs?

Subjects
United States. Food and Drug Administration, Medical marijuana, Nabilone, Opioid abuse -- Care and treatment, Substance abuse -- Care and treatment, Mental health, Social services, Buprenorphine, Marijuana, Health, Youth, Methadone, Central nervous system depressants, Family and marriage, Health, Psychology and mental health
Abstract

Gov. Andrew Cuomo of New York has added opioid use disorders (OUDs) to the list of approved conditions for which medical marijuana could be prescribed in the state, following the [...]

Published
2019

47. Buprenorphine patch 20mcg / hr

Subjects
Buprenorphine, Business, international
Abstract

Tenders are invited for Buprenorphine Patch 20Mcg / Hr Quantity: 50.00 Numbers Bidding System: Single Bid System Inspection Agency: Consignee Payment Terms: 100 Percent Against Supply Of Material And Acceptance [...]

Published
2015

48. Buprenorphine patch 20mcg / hr

Subjects
Buprenorphine, Business, international
Abstract

Tenders are invited for Buprenorphine Patch 20Mcg / Hr Quantity: 50.00 Numbers Bidding System: Single Bid System Inspection Agency: Consignee Payment Terms: 100 Percent Against Receipted Challan . Instructions/Remarks: A- [...]

Published
2015

49. Buprenorphine patch 10mcg /hr

Subjects
Buprenorphine, Business, international
Abstract

Tenders are invited for Buprenorphine Patch 10Mcg /Hr Quantity: 50.00 Numbers Bidding System: Single Bid System Inspection Agency: Consignee Payment Terms: 100 Percent Against Receipted Challan . Instructions/Remarks: A- Firm [...]

Published
2015